John H Johnson Insider Trading $SBBP Strongbridge Biopharma plc
Get free email notifications about insider trading for John H Johnson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John H Johnson. John H Johnson is CEO in IMCLONE SYSTEMS INC ($IMCLE) and Director in PORTOLA PHARMACEUTICALS INC ($PTLA) and Director in AVEO PHARMACEUTICALS INC ($AVEO) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in HISTOGENICS CORP ($HSGX) and Chief Executive Officer in MELINTA THERAPEUTICS, INC. /NEW/ ($MLNT) and Director in CEMPRA, INC. ($CEMP) and Interim CEO in MELINTA THERAPEUTICS, INC. /NEW/ ($MLNT) and Director in Verastem, Inc. ($VSTM) and Chief Executive Officer in Strongbridge Biopharma plc ($SBBP) and Director in Strongbridge Biopharma plc ($SBBP) and Executive Chairman in Strongbridge Biopharma plc ($SBBP).
John H Johnson in Strongbridge Biopharma plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John H Johnson: Chief Executive Officer, Executive Chairman, Director
Holdings: 995,827 shares
Latest Transaction: Apr 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John H Johnson in Strongbridge Biopharma plc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVEO, IMCLE, MLNT, HSGX, PTLA, SBBP, SCMP, VSTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 09 2021 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Chief Executive Off ... | Payment of Exercise | F | 2.68 | 17,325 | 46,431 | 995,827 | 1 M to 995.8 K (-1.71 %) |
| Jul 07 2020 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Chief Executive Off ... | Grant | A | 0.00 | 315,000 | 0 | 522,152 | 207.2 K to 522.2 K (+152.06 %) |
| May 18 2020 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Executive Chairman | Payment of Exercise | F | 2.86 | 15,348 | 43,895 | 207,152 | 222.5 K to 207.2 K (-6.90 %) |
| May 18 2020 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Executive Chairman | Payment of Exercise | F | 2.86 | 15,348 | 43,895 | 207,152 | 222.5 K to 207.2 K (-6.90 %) |
| Apr 10 2020 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Executive Chairman | Option Exercise | A | 1.90 | 87,500 | 166,250 | 87,500 | |
| Apr 10 2020 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Executive Chairman | Grant | A | 0.00 | 182,500 | 0 | 222,500 | 40 K to 222.5 K (+456.25 %) |
| Nov 18 2019 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Executive Chairman | Option Exercise | A | 1.56 | 275,000 | 429,000 | 275,000 | |
| May 16 2019 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Director | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
| May 17 2018 | SBBP | Strongbridge Bioph ... | JOHNSON JOHN | Director | Option Exercise | A | 7.75 | 40,000 | 310,000 | 40,000 |
Page: 1